United Therapeutics Corp. (UTHR)
463.91
-1.02
(-0.22%)
USD |
NASDAQ |
Jan 20, 11:02
United Therapeutics EPS Diluted (Quarterly): 7.161 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 338.70M |
| Revenue (Quarterly) | 799.50M |
| Total Expenses (Quarterly) | 460.80M |
| Enterprise Value | 17.25B |
| Gross Profit Margin (Quarterly) | 87.38% |
| Profit Margin (Quarterly) | 42.36% |
| Earnings Yield | 5.69% |
| Operating Earnings Yield | 6.78% |
| Normalized Earnings Yield | 5.752 |